Walgreens Boots Alliance ...

NASDAQ: WBA · Real-Time Price · USD
11.17
-0.07 (-0.62%)
At close: May 23, 2025, 3:59 PM
11.15
-0.18%
After-hours: May 23, 2025, 05:42 PM EDT

Walgreens Boots Alliance Revenue Breakdown

Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021 Aug 31, 2020 Aug 31, 2019 Aug 31, 2018 Aug 31, 2017
International Reportable Segment Revenue 23.55B 22.2B 21.83B 20.5B 107.7B 104.53B 98.39B 87.3B
International Reportable Segment Revenue Growth +6.10% +1.69% +6.46% -80.96% +3.03% +6.24% +12.70% n/a
Retail Pharmacy USA Revenue 115.78B 110.31B 109.08B n/a n/a n/a n/a n/a
Retail Pharmacy USA Revenue Growth +4.95% +1.13% n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Feb 28, 2025 Nov 30, 2024 Aug 31, 2024 May 31, 2024 Feb 29, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020 Feb 29, 2020 Nov 30, 2019 Aug 31, 2019 May 31, 2019 Feb 28, 2019 Nov 30, 2018 Aug 31, 2018 May 31, 2018 Feb 28, 2018 Nov 30, 2017 Aug 31, 2017 May 31, 2017 Feb 28, 2017 Nov 30, 2016 Aug 31, 2016 May 31, 2016 Feb 29, 2016 Nov 30, 2015 Aug 31, 2015 May 31, 2015 Feb 28, 2015
Selling, General, and Administrative Revenue 8.89B 7.01B 6.95B 6.39B 7.92B 6.85B 6.99B 7.12B 6.93B 13.16B 7.32B 7.02B 6.57B 6.39B 6.65B 6.12B 6.03B 5.79B 6.21B 7.88B 5.91B 6.26B 6.41B 6.24B 6.32B 6.28B 6.11B 6.24B 6.32B 5.91B 6.22B 5.71B 6.12B 5.69B 5.83B 5.9B 6.01B 5.95B 6.43B 6.08B 5.61B
Selling, General, and Administrative Revenue Growth +26.74% +0.96% +8.68% -19.29% +15.62% -1.99% -1.87% +2.73% -47.30% +79.75% +4.29% +6.92% +2.72% -3.89% +8.73% +1.44% +4.09% -6.73% -21.23% +33.42% -5.64% -2.28% +2.77% -1.34% +0.64% +2.73% -1.96% -1.36% +6.95% -4.95% +8.86% -6.73% +7.70% -2.39% -1.32% -1.73% +0.94% -7.44% +5.74% +8.46% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a